Cancer Society New Zealand to commence trial of oncology drug
New Zealand
New Zealand MEDSAFE grants approval for Invex’s IIH therapy trial
The variation in intracranial pressure, as evaluated by a lumbar puncture, at baseline and 24 weeks is the primary endpoint.
Pardes reports interim data from Phase I trial of oral Covid-19 antiviral
Sciwind commences dosing in Phase IIb obesity drug trial
Valneva commences Phase III trial of Covid-19 vaccine in New Zealand
Setback of Seres’s late-stage candidate challenges microbiome space – register for free webinar
Researchers conduct study to increase trial participation in New Zealand
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
